Nurr1 reduction influences the onset of chronic EAE in mice

Francesca Montarolo1, Simona Perga2, Serena Martire2

  • 1AOU San Luigi Gonzaga, Neurobiology Unit, Neurologia 2, CReSM (Regional Referring Center of Multiple Sclerosis) and Neuroscience Institute Cavalieri Ottolenghi (NICO), Regione Gonzole, 10, 10043, Orbassano, TO, Italy. francesca.montarolo@unito.it.

Abstract

Insights

Reduced Nurr1 (nuclear receptor 4A2) exacerbates experimental autoimmune encephalomyelitis (EAE), a model for multiple sclerosis. This suggests Nurr1 deficiency worsens early EAE onset and spinal cord inflammation.

Area of Science:

  • Neuroimmunology
  • Molecular Neuroscience

Background:

  • Nurr1 (nuclear receptor 4A2) exhibits anti-inflammatory properties in glial cells.
  • Down-regulation of Nurr1 in peripheral blood mononuclear cells (PBMCs) of multiple sclerosis (MS) patients correlates with disease severity.

Purpose of the Study:

  • To investigate the role of Nurr1 deficiency in the pathogenesis of experimental autoimmune encephalomyelitis (EAE), an animal model of MS.
  • To assess the impact of reduced Nurr1 on disease onset, progression, and neuroinflammation.

Main Methods:

  • EAE was induced in heterozygous Nurr1 knockout mice.
  • Clinical neurological scores were monitored throughout the pre-symptomatic, acute, and chronic disease phases.
  • Neuroinflammation and tissue damage were assessed in the spinal cord.

Main Results:

  • Nurr1 deficiency led to an earlier onset of EAE.
  • Increased inflammatory cell infiltration was observed in the spinal cords of Nurr1-deficient mice.
  • The severity of neuroinflammation was exacerbated by the reduction of Nurr1.

Conclusions:

  • A defect in Nurr1 function promotes early-onset EAE.
  • Nurr1 plays a critical role in modulating the inflammatory response during the early stages of EAE.
  • Targeting Nurr1 may offer therapeutic potential for mitigating early MS-like pathology.

Related Concept Videos